<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font19">and </span>
   <span class="font17">for </span>
   <span class="font13">doi: </span>
   <span class="font13">mAb </span>
   <span class="font13">;:–. </span>
   <span class="font12">that </span>
   <span class="font12">[]. </span>
   <span class="font12">delivery </span>
   <span class="font12">with </span>
   <span class="font12">are </span>
   <span class="font12">virus </span>
   <span class="font11">The </span>
   <span class="font11">mAbs </span>
   <span class="font11">from </span>
   <span class="font11">viral </span>
   <span class="font11">against </span>
   <span class="font11">clinical </span>
   <span class="font11">these </span>
   <span class="font11">{background </span>
   <span class="font11">antiviral </span>
   <span class="font11">have </span>
   <span class="font11">antibodies </span>
   <span class="font11">disease </span>
   <span class="font11">can </span>
   <span class="font11">infectious </span>
   <span class="font11">antibody </span>
   <span class="font11">use </span>
   <span class="font11">was </span>
   <span class="font11">been </span>
   <span class="font11">margin </span>
   <span class="font11">studies </span>
   <span class="font11">such </span>
   <span class="font11">which </span>
   <span class="font11">{border-style </span>
   <span class="font11">has </span>
   <span class="font11">levels </span>
   <span class="font10">DNA/EP </span>
   <span class="font10">gene </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">were </span>
   <span class="font10">however, </span>
   <span class="font10">into </span>
   <span class="font10">vivo </span>
   <span class="font10">muscle </span>
   <span class="font10">new </span>
   <span class="font10">serum </span>
   <span class="font10">NAb </span>
   <span class="font10">NAbs </span>
   <span class="font10">protein </span>
   <span class="font10">than </span>
   <span class="font10">delivered </span>
   <span class="font10">immune </span>
   <span class="font10">more </span>
   <span class="font10">novel </span>
   <span class="font10">there </span>
   <span class="font10">this </span>
   <span class="font10">HIV- </span>
   <span class="font10">[,]. </span>
   <span class="font10">al. </span>
   <span class="font10">monoclonal </span>
   <span class="font10">most </span>
   <span class="font10">order </span>
   <span class="font10">pDNA </span>
   <span class="font10">potential </span>
   <span class="font10">used </span>
   <span class="font10">vaccine </span>
   <span class="font10">DNA </span>
   <span class="font10">Ebola </span>
   <span class="font10">Indeed, </span>
   <span class="font10">Mol </span>
   <span class="font10">Ther. </span>
   <span class="font10">but </span>
   <span class="font10">drug </span>
   <span class="font10">first </span>
   <span class="font10">human </span>
   <span class="font10">manufacturing </span>
   <span class="font10">much </span>
   <span class="font10">not </span>
   <span class="font10">number </span>
   <span class="font10">outbreaks </span>
   <span class="font10">production </span>
   <span class="font10">therapy </span>
   <span class="font10">treatment </span>
   <span class="font10">well </span>
   <span class="font10">AAV </span>
   <span class="font10">This </span>
   <span class="font10">animal </span>
   <span class="font10">development </span>
   <span class="font10">drugs </span>
   <span class="font10">electrical </span>
   <span class="font10">expression </span>
   <span class="font10">injection </span>
   <span class="font10">large </span>
   <span class="font10">mRNA </span>
   <span class="font10">many </span>
   <span class="font10">neutralizing </span>
   <span class="font10">responses </span>
   <span class="font10">some </span>
   <span class="font10">technology </span>
   <span class="font10">would </span>
   <span class="font10">;:. </span>
   <span class="font10">al.A </span>
   <span class="font10">also </span>
   <span class="font10">including </span>
   <span class="font10">multiple </span>
   <span class="font10">nucleic </span>
   <span class="font10">platform </span>
   <span class="font10">rapidly </span>
   <span class="font10">therapeutic </span>
   <span class="font10">through </span>
   <span class="font10">transfer </span>
   <span class="font10">trial </span>
   <span class="font10">Zika </span>
   <span class="font10">ability </span>
   <span class="font10">broadly </span>
   <span class="font10">current </span>
   <span class="font10">diseases </span>
   <span class="font10">either </span>
   <span class="font10">electroporation </span>
   <span class="font10">outbreak </span>
   <span class="font10">process </span>
   <span class="font10">protection </span>
   <span class="font10">px; </span>
   <span class="font10">safety </span>
   <span class="font10">two </span>
   <span class="font10">typically </span>
   <span class="font10">vaccines </span>
   <span class="font10">{font-family </span>
   <span class="font10">./j.ymthe... </span>
   <span class="font10">DNA-based </span>
   <span class="font10">DNA/EP-mediated </span>
   <span class="font10">case </span>
   <span class="font10">cells </span>
   <span class="font10">combination </span>
   <span class="font10">concentrations </span>
   <span class="font10">font-size </span>
   <span class="font10">high </span>
   <span class="font10">humans. </span>
   <span class="font10">identification </span>
   <span class="font10">infection. </span>
   <span class="font10">influenza </span>
   <span class="font10">pandemic </span>
   <span class="font10">prevention </span>
   <span class="font10">rapid </span>
   <span class="font10">reduce </span>
   <span class="font10">severe </span>
   <span class="font10">significant </span>
   <span class="font10">study </span>
   <span class="font10">their </span>
   <span class="font10">they </span>
   <span class="font10">when </span>
   <span class="font10">within </span>
   <span class="font10">work </span>
   <span class="font10">EID </span>
   <span class="font10">For </span>
   <span class="font10">Med. </span>
   <span class="font10">able </span>
   <span class="font10">acid </span>
   <span class="font10">acute </span>
   <span class="font10">administration </span>
   <span class="font10">advances </span>
   <span class="font10">already </span>
   <span class="font10">approval </span>
   <span class="font10">both </span>
   <span class="font10">capable </span>
   <span class="font10">designed </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">emerging </span>
   <span class="font10">expressed </span>
   <span class="font10">global </span>
   <span class="font10">important </span>
   <span class="font10">largely </span>
   <span class="font10">like </span>
   <span class="font10">may </span>
   <span class="font10">one </span>
   <span class="font10">overall </span>
   <span class="font10">particularly </span>
   <span class="font10">potent </span>
   <span class="font10">relevant </span>
   <span class="font10">response </span>
   <span class="font10">specific </span>
   <span class="font10">studies, </span>
   <span class="font10">systemic </span>
   <span class="font10">target </span>
   <span class="font10">technologies </span>
   <span class="font10">three </span>
   <span class="font10">vaccination </span>
   <span class="font10">weeks </span>
   <span class="font10">where </span>
   <span class="font10">COVID- </span>
   <span class="font10">COVID-, </span>
   <span class="font10">IAV </span>
   <span class="font10">Microbes </span>
   <span class="font10">NAb, </span>
   <span class="font10">Nat </span>
   <span class="font10">Sci. </span>
   <span class="font10">These </span>
   <span class="font10">accelerated </span>
   <span class="font10">acid-based </span>
   <span class="font10">after </span>
   <span class="font10">al.In </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">combinations </span>
   <span class="font10">contrast </span>
   <span class="font10">could </span>
   <span class="font10">countermeasures </span>
   <span class="font10">currently </span>
   <span class="font10">deliver </span>
   <span class="font10">developing </span>
   <span class="font10">different </span>
   <span class="font10">due </span>
   <span class="font10">effective </span>
   <span class="font10">evaluate </span>
   <span class="font10">even </span>
   <span class="font10">facilitate </span>
   <span class="font10">few </span>
   <span class="font10">general </span>
   <span class="font10">identify </span>
   <span class="font10">increase </span>
   <span class="font10">infection </span>
   <span class="font10">infections </span>
   <span class="font10">infections. </span>
   <span class="font10">just </span>
   <span class="font10">medical </span>
   <span class="font10">mice </span>
   <span class="font10">months </span>
   <span class="font10">mouse </span>
   <span class="font10">must </span>
   <span class="font10">neutralization </span>
   <span class="font10">only </span>
   <span class="font10">other </span>
   <span class="font10">part </span>
   <span class="font10">patients </span>
   <span class="font10">peak </span>
   <span class="font10">performed </span>
   <span class="font10">phase </span>
   <span class="font10">plasmid </span>
   <span class="font10">prevent </span>
   <span class="font10">pulses </span>
   <span class="font10">recent </span>
   <span class="font10">recently </span>
   <span class="font10">relatively </span>
   <span class="font10">respiratory </span>
   <span class="font10">revealed </span>
   <span class="font10">same </span>
   <span class="font10">sheep </span>
   <span class="font10">skeletal </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">strategy </span>
   <span class="font10">time </span>
   <span class="font10">treating </span>
   <span class="font10">trials </span>
   <span class="font10">using </span>
   <span class="font10">virus, </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses </span>
   <span class="font10">will </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Figure </span>
   <span class="font10">(www.clinicaltrials.gov </span>
   <span class="font10">./s--- </span>
   <span class="font10">AAV-based </span>
   <span class="font10">AAV-mediated </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Curr </span>
   <span class="font10">DNA-encoded </span>
   <span class="font10">EID, </span>
   <span class="font10">Engl </span>
   <span class="font10">FDA </span>
   <span class="font10">Gene </span>
   <span class="font10">However, </span>
   <span class="font10">Identifier: </span>
   <span class="font10">Influenza </span>
   <span class="font10">New </span>
   <span class="font10">PatelA, </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Virol. </span>
   <span class="font10">[–]. </span>
   <span class="font10">achieve </span>
   <span class="font10">achieved </span>
   <span class="font10">all </span>
   <span class="font10">animals </span>
   <span class="font10">another </span>
   <span class="font10">antigen </span>
   <span class="font10">approved </span>
   <span class="font10">associated </span>
   <span class="font10">average </span>
   <span class="font10">bNAbs </span>
   <span class="font10">because </span>
   <span class="font10">best </span>
   <span class="font10">between </span>
   <span class="font10">body </span>
   <span class="font10">bold </span>
   <span class="font10">breadth </span>
   <span class="font10">care </span>
   <span class="font10">chikungunya </span>
   <span class="font10">containing </span>
   <span class="font10">cost </span>
   <span class="font10">countermeasure </span>
   <span class="font10">courier; </span>
   <span class="font10">delivering </span>
   <span class="font10">delivery, </span>
   <span class="font10">delivery. </span>
   <span class="font10">demonstrated </span>
   <span class="font10">devices </span>
   <span class="font10">diseases, </span>
   <span class="font10">down </span>
   <span class="font10">early </span>
   <span class="font10">electroporation. </span>
   <span class="font10">em; </span>
   <span class="font10">encoding </span>
   <span class="font10">established </span>
   <span class="font10">evaluating </span>
   <span class="font10">example, </span>
   <span class="font10">existing </span>
   <span class="font10">far </span>
   <span class="font10">greatly </span>
   <span class="font10">highly </span>
   <span class="font10">hope </span>
   <span class="font10">humans </span>
   <span class="font10">improving </span>
   <span class="font10">issues </span>
   <span class="font10">known </span>
   <span class="font10">load </span>
   <span class="font10">majority </span>
   <span class="font10">manufacture </span>
   <span class="font10">models </span>
   <span class="font10">need </span>
   <span class="font10">particular </span>
   <span class="font10">price </span>
   <span class="font10">product </span>
   <span class="font10">programme </span>
   <span class="font10">promise </span>
   <span class="font10">proof-of-concept </span>
   <span class="font10">protect </span>
   <span class="font10">protects </span>
   <span class="font10">pt;} </span>
   <span class="font10">required </span>
   <span class="font10">response. </span>
   <span class="font10">resulted </span>
   <span class="font10">results </span>
   <span class="font10">scale </span>
   <span class="font10">seen </span>
   <span class="font10">several </span>
   <span class="font10">significantly </span>
   <span class="font10">spreading </span>
   <span class="font10">standard </span>
   <span class="font10">sufficient </span>
   <span class="font10">synthetic </span>
   <span class="font10">system </span>
   <span class="font10">technologies, </span>
   <span class="font10">timelines </span>
   <span class="font10">transmission </span>
   <span class="font10">very </span>
   <span class="font10">volume </span>
   <span class="font10">way </span>
   <span class="font10">yet </span>
  </p>
 </body>
</html>
